Insight

Michiel van der Heijden: Explaining inconsistent results in urothelial cancer with chemo plus IO

Photo of Michiel van der Heijden from X

Jul 31, 2024, 11:44

Michiel van der Heijden: Explaining inconsistent results in urothelial cancer with chemo plus IO

Michiel van der Heijden, Medical Oncologist at Netherlands Cancer Institute, shared on X:

“Results of chemo plus IO have produced inconsistent results in urothelial cancer. Opposing effects of pro- and anti-inflammatory changes may explain some of this.”

Read further.
Source: Michiel van der Heijden/X

Michiel van der Heijden

Authors: Maksim A. Chelushkin, Jeroen van Dorp, Sandra van Wilpe, Iris M. Seignette, Jan-Jaap J. Mellema, Maartje Alkemade, Alberto Gil-Jimenez, Dennis Peters, Wim Brugman, Chantal F. Stockem, Erik Hooijberg, Annegien Broeks, Bas W.G. van Rhijn, Laura S. Mertens, Antoine G. Van der Heijden, Niven Mehra, Maurits L. van Montfoort, Lodewyk F.A. Wessels, Daniel J. Vis, Michiel S. Van der Heijden

Platinum-based chemotherapy induces opposing effects on immunotherapy response-related spatial and stromal biomarkers in the bladder cancer microenvironment

Alberto Gil-Jimenez Annegien Broeks Antoine G. Van der Heijden Bas W.G. van Rhijn cancer Chantal F. Stockem Daniel J. Vis Dennis Peters Erik Hooijberg Iris M. Seignette Jan-Jaap J. Mellema Jeroen van Dorp Laura S. Mertens Lodewyk F.A. Wessels Maartje Alkemade Maksim A. Chelushkin Maurits L. van Montfoort Michiel S. Van der Heijden Michiel van der Heijden Netherlands Cancer Institute Niven Mehra OncoDaily Oncology Sandra van Wilpe Wim Brugman

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage